Physician Photo

Lisa B. Nachtigall, MD

Co-director Neuroendocrine Clinical Center

  • Phone: 617-726-7948
Departments
Neuroendocrinology
Department of Medicine
Clinical Interests
Bone disorders related to neuroendocrine dysfunction
Pituitary disease
Hyperprolactinemia
Pituitary tumors
Acromegaly
Reproductive Dysfunction
Hypopituitarism
Hirsuitism
Hyperandrogenism
Locations
Boston: Massachusetts General Hospital
Medical Education
MD, New York University School of Medicine
Residency, New York University School of Medicine
Fellowship, Massachusetts General Hospital
Board Certifications
Endocrinology, Diabetes & Metabolism, American Board of Internal Medicine
Gender
Female
Patient Age Group
Adult
Accepting New Patients
Yes

Biography

Dr. Lisa Nachtigall is the Co- Director of the Neuroendocrine Clinical Center at Massachusetts General Hospital and Assistant Professor of Medicine at Harvard Medical School.   Her primary clinical focus is pituitary disorders and the treatment of patients with acromegaly.  She has extensive clinical experience in neuroendocrine disorders and has published clinical research papers in this area. She has received awards for teaching and clinical investigation.

Research

My study of how 100 patients with acromegaly came to diagnosis targeted education on this rare disease to professionals who most likely encounter it. I investigated a long acting somatostatin analog with a novel delivery system. I have contributed to several reviews on acromegaly and hyperprolactinemia and edited chapters on these topics. I have created an acromegaly database, including longitudinal data in over 350 patients, which will improve clinical practice strategies and serve as a resource for clinical investigation and as a model for database construction. I received an investigator initiated award to study long term treatment of acromegaly with somatostatin analogs.

Publications

View my most recent publications at PubMed

Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement.

Miller KK, Wexler T, Fazeli P, Gunnell L, Graham GJ, Beauregard C, Hemphill L, Nachtigall L, Loeffler J, Swearingen B, Biller BM, Klibanski A. J Clin Endocrinol Metab. 2010 Feb;95(2):567-77. Epub 2010 Jan 8.

Effectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-na?ve patients with acromegaly.

Salvatori R, Nachtigall LB, Cook DM, Bonert V, Molitch ME, Blethen S, Chang S; SALSA Study Group. Pituitary. 2010 Jun;13(2):115-22.

Neuroendocrine Clinical Center
Zero Emerson Place
Suite 112
Boston, MA 02114-2217

Phone: 617-726-7948
Fax: 617-726-1241